Compare Revvity Inc (RVTY) vs Vanguard Intermediate Term Corporate Bond ETF (VCIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Vanguard Intermediate Term Corporate Bond ETF — how do they compare? Revvity Inc trades at $115.05 (market cap $12.91B), while Vanguard Intermediate Term Corporate Bond ETF trades at $81.3. The key difference: Revvity Inc pays a 0.24% dividend while Vanguard Intermediate Term Corporate Bond ETF pays none, and Revvity Inc is trading nearer its 52-week high, Vanguard Intermediate Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| RVTY | VCIT | |
|---|---|---|
Market Cap | $12.91B | — |
Sector | Technology | Fixed Income |
52-Week High | $117.75 | $84.82 |
52-Week Low | $82.26 | $81.07 |
Enterprise Value | $15.23B | — |
Dividend Yield | 0.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Vanguard Intermediate Term Corporate Bond ETF
VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →
